Boston, MA, United States of America

Jeffrey I Zwicker

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jeffrey I. Zwicker

Introduction

Jeffrey I. Zwicker is a notable inventor based in Boston, MA, with a focus on medical advancements. He holds three patents that contribute significantly to the field of healthcare, particularly in treating serious conditions such as sickle cell disease and thrombotic events in cancer patients.

Latest Patents

One of his latest patents is a method for treating sickle cell disease using quercetin-containing compositions. This invention discloses compositions and methods for treating sickle cell disease, including the administration of isoquercetin, vitamin B3, vitamin C, and optionally folic acid. The effective amount of these components is sufficient to halt the progression of one or more symptoms of sickle cell disease. Another significant patent involves methods for reducing major thrombotic events in cancer patients. This invention relates to methods for reducing soluble P-selectin and major thrombotic events, which are critical for improving patient outcomes in oncology.

Career Highlights

Jeffrey I. Zwicker is affiliated with Beth Israel Deaconess Medical Center, Inc., where he applies his expertise in medical research and innovation. His work has been instrumental in developing new therapeutic strategies that address pressing health issues.

Collaborations

He has collaborated with esteemed colleagues such as Bruce Furie and Robert Flaumenhaft, contributing to a rich environment of innovation and research.

Conclusion

Jeffrey I. Zwicker's contributions to medical science through his patents reflect his commitment to improving patient care and advancing healthcare solutions. His work continues to inspire future innovations in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…